Medical Research and Clinical Trials

OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector

• Medical Research and Clinical Trials

OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector

Rifan Muazin September 17, 2026

To create a comprehensive news article of that length and structure, I would need actual news content,...

Read More Read more about OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector

Unveiling the Colorectal Cancer Paradox: A Dual Role for Regulatory T Cells Offers New Hope

• Medical Research and Clinical Trials

Unveiling the Colorectal Cancer Paradox: A Dual Role for Regulatory T Cells Offers New Hope

Basiran September 16, 2026

New York, NY – In a significant stride forward for cancer immunotherapy, researchers at the Sloan Kettering...

Read More Read more about Unveiling the Colorectal Cancer Paradox: A Dual Role for Regulatory T Cells Offers New Hope

Axoltis Pharma Navigates ALS Development Challenges with Promising Exploratory Data Amidst Stricter Regulatory Landscape

• Medical Research and Clinical Trials

Axoltis Pharma Navigates ALS Development Challenges with Promising Exploratory Data Amidst Stricter Regulatory Landscape

Nana September 16, 2026

Boston, MA – [Insert Date] – The relentless pursuit of effective treatments for Amyotrophic Lateral Sclerosis (ALS)...

Read More Read more about Axoltis Pharma Navigates ALS Development Challenges with Promising Exploratory Data Amidst Stricter Regulatory Landscape

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Promote Growth

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Promote Growth

Basiran September 16, 2026

NORMAN, OK – In a significant stride towards understanding and potentially conquering one of the most formidable...

Read More Read more about Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Promote Growth

Groundbreaking Obesity Therapy SYNT-101 Shows Promising Safety and Efficacy in Phase I/Ib Trial, Mimicking Bariatric Surgery Effects Orally

• Medical Research and Clinical Trials

Groundbreaking Obesity Therapy SYNT-101 Shows Promising Safety and Efficacy in Phase I/Ib Trial, Mimicking Bariatric Surgery Effects Orally

Nila Kartika Wati September 16, 2026

Syntis Bio’s novel oral therapy, SYNT-101, has achieved a significant milestone in its development, demonstrating excellent tolerability...

Read More Read more about Groundbreaking Obesity Therapy SYNT-101 Shows Promising Safety and Efficacy in Phase I/Ib Trial, Mimicking Bariatric Surgery Effects Orally

Unveiling the Silent Threat: Genetics and Treatment Share Blame for Secondary Cancers in Childhood Survivors

• Medical Research and Clinical Trials

Unveiling the Silent Threat: Genetics and Treatment Share Blame for Secondary Cancers in Childhood Survivors

Siti Muinah September 16, 2026

New St. Jude Research Quantifies Contributions, Revolutionizing Future Care Paradigms Main Facts MEMPHIS, TN – A groundbreaking...

Read More Read more about Unveiling the Silent Threat: Genetics and Treatment Share Blame for Secondary Cancers in Childhood Survivors

US FDA Launches Expedited IND Pilot Under Operation Trialblazer to Reclaim Leadership in Early-Stage Clinical Trials

• Medical Research and Clinical Trials

US FDA Launches Expedited IND Pilot Under Operation Trialblazer to Reclaim Leadership in Early-Stage Clinical Trials

Siti Muinah September 16, 2026

Washington D.C. – The U.S. Food and Drug Administration (FDA) is poised to launch a groundbreaking expedited...

Read More Read more about US FDA Launches Expedited IND Pilot Under Operation Trialblazer to Reclaim Leadership in Early-Stage Clinical Trials

Definium Therapeutics Poised to Submit NDA for DT120 in GAD by Mid-2027, Signaling a New Era for Psychedelic Medicine

• Medical Research and Clinical Trials

Definium Therapeutics Poised to Submit NDA for DT120 in GAD by Mid-2027, Signaling a New Era for Psychedelic Medicine

Evan Lee Salim September 15, 2026

San Francisco, CA – [Insert Date] – Definium Therapeutics has announced its strategic intent to file a...

Read More Read more about Definium Therapeutics Poised to Submit NDA for DT120 in GAD by Mid-2027, Signaling a New Era for Psychedelic Medicine

Novartis Faces Heightened Scrutiny as Bolt-On Strategy Undergoes Crucial Test

• Medical Research and Clinical Trials

Novartis Faces Heightened Scrutiny as Bolt-On Strategy Undergoes Crucial Test

Reynand Wu September 15, 2026

The pharmaceutical giant Novartis is navigating a period of intense pressure, with its carefully crafted "bolt-on" acquisition...

Read More Read more about Novartis Faces Heightened Scrutiny as Bolt-On Strategy Undergoes Crucial Test

New Hope for Menopausal Heart Health: Study Unveils Long-Term Cardiovascular Benefits of Hormone Therapy

• Medical Research and Clinical Trials

New Hope for Menopausal Heart Health: Study Unveils Long-Term Cardiovascular Benefits of Hormone Therapy

Lina Irawan September 14, 2026

UNIVERSITY PARK, PA – The decision to embark on hormone therapy (HT) during the menopause transition, a...

Read More Read more about New Hope for Menopausal Heart Health: Study Unveils Long-Term Cardiovascular Benefits of Hormone Therapy